鶹ýɫƬ

Profile

From antibiotic resistance to an antibody targeting immune cells

MOSAIC scholar Diego Pedroza got his start in chemistry, then moved to molecular biology, endocrinology and testing cancer drugs
Carmen Morcelle
By Carmen Morcelle
Jan. 15, 2025

When Diego Pedroza was a child growing up in Texas, his father would tell him how the human body works. 

“Even though my dad didn’t go to college, he would read a lot about biology and physics and talk about it,” Pedroza said. “He explained that illnesses come from viruses and bacteria invading our bodies or that proteins help build muscle when you lift weights.”

Diego Pedroza published his first manuscript as an undergraduate and then struggled to win grants when he was a postdoc.

Pedroza’s interest grew in high school when he began taking chemistry and biology classes.

“I had a high school teacher who asked me to write about antibiotic resistance, which is a problem in my hometown, El Paso,” he said. “I remember looking at the chemical structure of two different antibiotics. I didn’t understand much at that time, but I thought it was very cool. I just fell in love with it.”

Initially drawn to chemistry, Pedroza pursued a degree in biochemistry at the University of Texas at El Paso and volunteered in Shizue Mito’s lab where he worked on synthesizing amino acids.

When he was awarded a summer internship at Texas Tech University Health Sciences Center El Paso, he began working on breast cancer, molecular biology and endocrinology; it was completely different from the chemistry research he knew.

“I also fell in love with it,” he said. “I thought that was even cooler, because I was testing drug compounds on cancer cells, and it felt like I was doing something that could truly make a difference.”

 After the internship, Pedroza returned to the University of Texas at El Paso and joined ’s lab, where he was able to combine his previous experiences to test whether synthesized compounds from his first lab could kill cancer cells. The project led to an exciting milestone: writing his first scientific manuscript.

“To my surprise, it got published,” he said. “As an undergrad, having a first-author paper was a huge confidence boost — it made me feel like I belonged in research.”

Pedroza continued to work in Rajkumar Lakshmanaswamy’s lab while earning his master’s degree at Texas Tech University. He focused on studying hormones in the breast and decided he wanted to dedicate his life to research. After his master’s, he earned a Ph.D. in the same lab, publishing four first-author papers and contributing to others’ manuscripts. Again, he felt like he belonged.

Pedroza accepted a postdoctoral position at Baylor College of Medicine in the labs of Jeffrey Rosen and Xiang H-F Zhang, where he faced a challenging period of grant rejections, with about eight or nine submissions turned down.

“My boss was very supportive and encouraged me to keep trying, but I was devastated when one grant was triaged,” he said. “For a month, I even thought my career as a scientist might be over.”

His perseverance paid off when he received the results of a three-year grant application from the American Cancer Society — a perfect score. After that, he also entered the 鶹ýɫƬ and 鶹ýɫƬ Biology’s , or MOSAIC, program, which supports postdocs and new investigators  from diverse backgrounds who are embarking on careers at research-intensive institutions.

Pedroza has benefited from the program’s mentorship.

“I’ve already had the opportunity to take advantage of the program by talking to one MOSAIC mentor who has given me advice on the next steps in my career,” he said.

In the lab, Pedroza is working on targeting tumor-associated macrophages, immune cells that infiltrate tumors and help cancer cells rather than attacking them. In genetically modified mice, he found that combining an antibody targeting these macrophages with chemotherapy and anti-PD-1 therapy not only works but also shows prolonged antitumor effects in lung and liver metastases.

For aspiring researchers, Pedroza has just one piece of advice.

“Do not just do one thing,” he said. “Explore different fields. Do chemistry, do physics, cell biology, molecular biology … Eventually, you’ll find the one thing you love.”

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Carmen Morcelle
Carmen Morcelle

Carmen Morcelle is a postdoctoral researcher working at the Ragon Institute of Massachusetts General Hospital, the Massachusetts Institute of Technology and Harvard University in Boston.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Meet the 2025 SOC grant awardees
Outreach

Meet the 2025 SOC grant awardees

Aug. 15, 2025

Five science outreach and communication projects received up to $1,000 from ASBMB to promote the understanding of molecular life science.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.

In memoriam: William S. Sly
In Memoriam

In memoriam: William S. Sly

Aug. 11, 2025

He served on the 鶹ýɫƬ and 鶹ýɫƬ Biology Council in 2005 and 2006 and was an ASBMB member for 35 years.

ASBMB committees welcome new members
Society News

ASBMB committees welcome new members

Aug. 7, 2025

Members joined these committees: Education and Professional Development, Maximizing Access, Meetings, 鶹ýɫƬ, Public Affairs Advisory, Science Outreach and Communication, Student Chapters and Women in Biochemistry and 鶹ýɫƬ Biology.